Developing Story: How PCDI Is Changing the Way We Think About Dosing
Treatment Decisions, Expert Interviews, Patient Education, Patient Empowerment, FDA, Health & Medicine, Cancer Care, Patient Advocacy, Medical Research, Metastatic Breast Cancer LiveFromStage4 Podcast Treatment Decisions, Expert Interviews, Patient Education, Patient Empowerment, FDA, Health & Medicine, Cancer Care, Patient Advocacy, Medical Research, Metastatic Breast Cancer LiveFromStage4 Podcast

Developing Story: How PCDI Is Changing the Way We Think About Dosing

What if the highest dose isn't the right dose? Victoria talks with the Patient-Centered Dosing Initiative team about two groundbreaking surveys revealing that lower doses of cancer drugs can be just as effective, while dramatically improving quality of life. Learn why patients are having dose reduction conversations with their doctors, what real-world data shows about side effects, and how you can advocate for personalized treatment.

Read More
Developing Story: The Camizestrant Vote — When Your Blood Test Knows Before Your Scan Does
Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast

Developing Story: The Camizestrant Vote — When Your Blood Test Knows Before Your Scan Does

Six MBC patient advocates join host Victoria Goldberg to break down the FDA advisory committee's vote on camizestrant and the SERENA-6 trial. The panel unpacks what the vote really means, whether the science of molecular progression is ready for clinical practice, and why patient advocates need a seat at the table before trials are designed.

Read More